Viacheslav Morozov

机构：University of Florida · ORCID：0000-0002-4901-7722

发表论文 37 篇 · 总被引 944 次 · h-index 17

代表论文

• Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries (2019 · Clinical Gastroenterology and Hepatology · 被引 114)
• Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial (2024 · Journal of Hepatology · 被引 82)
• Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial (2023 · ˜The œLancet. Gastroenterology & hepatology · 被引 82)
• Inhibitor of H3K27 demethylase JMJD3/UTX GSK-J4 is a potential therapeutic option for castration resistant prostate cancer (2017 · Oncotarget · 被引 70)
• Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy (2013 · Cell Cycle · 被引 47)
• CENP-B protects centromere chromatin integrity by facilitating histone deposition via the H3.3-specific chaperone Daxx (2017 · Epigenetics & Chromatin · 被引 42)